A biodegradable copolymer of polylactide-polyglycolide was combined with allogeneic demineralized freeze-dried bone (DFDB) and implanted into 15-mm diameter defects in the calvaria of 26 New Zealand White rabbits. Similar defects were created in the calvaria of another 26 rabbits. These animals served as controls and did not receive copolymer implants. Upon sacrifice, both the implants and the controls were evaluated clinically, roentgenographically, and histomorphometrically using a Zeiss Image Analysis System (Videoplan, version 4.1). Both controls and implants were evaluated in groups at four, eight, 12, 16, 20, and 24 weeks. When compared with the control defects, the copolymer-DFDB implants displayed a significantly greater volume of trabecular bone. Three of the 15-mm diameter defects displayed evidence of complete osseous bridging a t eight weeks. No adverse host-tissue responses were observed histologically in any of the implant specimens.
cal management. These wounds commonly present as irregularly shaped discontinuity defects that require some form of bone graft to restore continuity. Defects in the maxillofacial region often occur on broad, flat regions of the skull and face where soft-tissue support and facial esthetics are important considerations. A desirable bone repair material should be osteogenic, easily adaptable at the time of surgery, and rigid enough to support the muscles and soft tissues of the face.
For the repair of craniomaxillofacial fibrous union defects, bone obtained from the iliac crest, with its high cancellous-to-cortical ratio, is considered the grafting material of choice.21 However, bone grafts present special problems, including the need for a separate harvesting procedure with its attendant morbidity, the potential limitation of available donor bone, and a failure rate of 9%-19% for grafts to the maxillofacial region. I . 17. 23 The advantages and disadvantages of autogeneic grafts versus alloplastic materials have been reviewed by W01fe.~~
The alpha-hydroxy polyesters, polylactide (PLA) and polyglycolide (PGA), have been investigated for use as implant materials in the repair of a variety of soft-tissue and osseous wounds. Implanted homopolymers and copolymers of PLA and PGA have been used in a supportive role as suture material, orbital Schmitz and Hollinger and Related Research fied for 24 hrs in 0.6 N HCI at 4 ' , rinsed in 0.1 M phosphate buffered saline (PBS) and distilled water, and lyophilized. PLA-PGA copolymer (1 g) was solubilized in chloroform, precipitated with methanol, and combined with DFDB (500 mg). The doughy composite was forced into Teflon (Dupont, Wilmington, Delaware) molds and heatcured for 24 hours at 45"-48". After sterilization with ethylene oxide at room temperature, the implants were lyophilized for 84 hours at 50 millitorr to remove ethylene oxide residuals.28 Scanning electron micrographs of the lyophilized implants revealed a polymer lattice interspersed with bone matrix particles ( Fig. 1 floor replacements, dressings to facilitate healing in tooth extraction sites, and as biodegradable bone plates and screw^.^-^'^ In the early 1960s, U r i~t~~ discovered that consistent osteoinduction by demineralized bone matrix could be achieved by the control of time, temperature, and molar concentration of HCl. Allogeneic demineralized bone implants subsequently have been used clinically for the correction of craniomaxillofacial deformities and in the treatment of jaw defects. 10.18. 24 This study examined the osteogenic potential of a biodegradable copolymer (PLA-PGA) combined with allogeneic demineralized freeze-dried bone (DFDB) for craniotomy wound repair.
MATERIALS AND METHODS

IMPLANT PREPARATION
A composite alloimplant was prepared by combining 5050 poly (DL-lactide-co-glycolide) (PLA: PGA) with an inherent viscosity of 0.92 with allogeneic DFDB. Diaphyseal segments of long bones were removed from donor animals (New Zealand White rabbits) and pulverized in the cold (8") to a particle size of 150-590 pm. The particles were defatted in 100% ethanol for four hours, decaici-SURGERY Fifty-two adult male New Zealand White rabbits were randomly selected and conditioned for two weeks prior to the beginning of the experiment. Adult status was documented by roentgenographic confirmation of tibia1 epiphyseal plate closure. The animals were anesthetized using a xylazine/ketamine technique supplemented with 1.8 ml of 2% lidocaine hydrochloride with 1: 100,000 epinephrine. The scalp hair was removed with a depilating agent and the area over the calvaria was scrubbed with ethyl alcohol and povidone iodine for five minutes. Before surgery, 150,000 units of Rocillin (Brystol Myers, Syracuse, New York) were administered intramuscularly in the left hind leg.
Following attainment of a suitable level of anesthesia, an incision was made in the midline from the area of the superior sagittal crest to the middle of the nasal bone. The soft tissues were gently reflected laterally and a 15-mm diameter craniotomy was created using a trephine in a slow-speed dental handpiece (Figs. 2A and 2B). Copious inigation with normal saline was used throughout the procedure. Care was taken during the entire process to avoid perforating the dura and the superior sagittal sinus. The craniotomy was then irrigated with normal saline.
Twenty-six of the animals served as controls while the other 26 animals received circular implant discs (Fig. 3) . The periosteum was closed over all the defects and implants and the tissues were closed in layers with No. 3-0 polyglycolic acid suture. At four, eight, 12, 16,20, and 24 weeks animals were killed with an overdose of sodium pentothal, USP (Table I) .
The defects and implants were retrieved along with surrounding host bone and immediately fixed in 70% ethanol. Specimens were removed from the fixative, placed dura-side down on Kodak U1traspeed Dental X-ray film (Eastman Kodak, Rochester, New York) and roentgenographed at 90 KVP, 10 Ma, 0.4 seconds using a long-cone technique. Each roentgenogram was developed in an automatic X-ray processor and printed using a standard enlargement magnification. Specimens were subsequently embedded in polymethylmethacrylate, sectioned at 6 pm, and stained with a modified Masson-Goldner trichrome stain. Slides were analyzed using a Zeiss Universal microscope (New York, New York; X 15.6 magnification) that was interfaced with a Zeiss Image Analysis System (Videoplan, version 4.1). Six contiguous fields that extended symmetrically across the center of the defect were measured. The total trabecular volume (inclusive of calcified trabeculae and osteoid) of new bone was quantified for each temporal group (Table 1) . diameter defects healed in 24 weeks, healing was characterized by varying amounts of fibrous tissue repair ( Fig. 4) .
RESULTS
GROSS EXAMINATION
T h e control defects began healing in a tentripetal fashion. Although none of the 15-mm At week 4 the implants showed extensive fibrous encapsulation without significant degradation of the polymer (Fig. 5 ). The implants appeared to have swollen to the point of protruding from the defect. The wound margins could still be identified.
From week 8 to week 16 the implants revealed varying amounts of osteosclerotic rimming at the wound margins and a reddishbrown soft tissue within the center of the defect ( Fig. 6 ). In many specimens the central area of the defect still contained areas of re-sidual polymer. From week 20 to week 24, organized soft-tissue elements and residual polymer were apparent. In implant sites that did not heal, dark red soft-tissue was present in the center of the wound.
The implants were well-tolerated by all the experimental animals. No adverse soft-tissue reactions developed in any of the surgical sites. At necropsy, two of the five implanttreated wounds completely bridged the calvarial defect with bone at eight weeks. The copolymer implants were not completely degraded in all instances at 24 weeks; however, this did not appear to interfere with bone formation.
FIG. 4. Control defect at retrieval at week 8. Fibrous repair tissue is present as a thin membrane over the defect. The wound margins are clearly demarcated (arrows).
FIG. 5. Implant at retrieval at week 4. The implant has swollen within the defect and has a fibrous tissue capsule present over it. 
ROENTGENOGRAPHIC EXAMINATION
Control wounds demonstrated a centripetal pattern of bony repair characterized by fingerlike extensions and occasional islands of osseous repair. None of the control wounds displayed roentgenographic evidence of osseous bridging at 24 weeks (Fig. 7) .
The implants demonstrated a pattern of bony repair that appeared to proceed centripetally as the polymer degraded. Two of the five implants showed trabecular patterns indicative of complete repair at eight weeks. Coalescing bony elements were present as irregular fingers and isolated areas of speckled radiopacities (Fig. 8 ).
HISTOLOGIC EXAMINATION
By week 4 the control sites showed isolated islands of trabecular bone within the defect surrounded by fibrous connective tissue. Wound margins were not eburnated at this time. From week 8 to week 12 isolated areas of reparative elements were still present with apparent eburnation of the bony margins. The osseous islands appeared to increase in size with time. Many of these islands contained hematopoietic elements. From week 16 to week 24 islands of reparative elements became more numerous and incomplete 0sseous bridging was observed ( Fig. 9) . A fibrous connective-tissue membrane was the distinctive feature in all incompletely healed defects.
The implants at week 4 showed isolated islands of bony trabeculae throughout the de- From week 8 to week 12 residual polymer was still present in the experimental defects. Islands of reparative bone were seen extending completely across the defect in three defects ( Fig. ll) . From week 16 to week 24 in areas devoid of healing, bone particles were occasionally present and appeared to be enveloped by fibrous connective tissue. Large islands of coalescing trabeculae were observed with areas of residual demineralized bone surrounded by a prominent round-cell infiltrate. Residual copolymer was present in many implant-treated wounds at 24 weeks.
HISTOMORPHOMETRIC ANALYSIS
The mean pooled trabecular bony area (TBA) in the experimental and control ani-mals was analyzed using an unpaired Student's t-test (Table 1 ). There was a significant difference in the pooled mean trabecular bony volume between the implant and the control sites (p < 0.05). When the control and implant groups were assessed over time, there was no significant difference using a one-way analysis of variance (p > 0.05). The rather large standard deviations reflected the inconsistent pattern of trabecular formation that characterized the center of the defects.
DISCUSSION
Traumatic avulsive wounds and ablative surgical defects commonly result in fibrous union or nonunion discontinuity defects. In testing novel bone repair materials (BRM), an appropriate animal system that consistently reproduces these defects is essential to predicting success in clinical trials. The use of critical size defects (CSD) insures a nonunion wound that will not repair spontaneously with bone.33 A CSD may be defined as the smallest sized intraosseous wound in a particular bone and species of animal that will not heal spontaneously with bone during the lifetime of the Since many bones of the skull and face are of intramembranous origin, it is imperative to test novel bone repair materials in an intramembranous site such as the calvaria, rather than in an endochondral site such as a long bone. The use of a rabbit calvarial CSD model using 15-mm diameter defects satisfies both of these prerequisites and also obviates the need for rigid fixation appliances.' Biodegradable polymers previously have been investigated for use in soft-and hardtissue repair, in the internal fixation of fractures, and as intraosseous bone repair materials. A promising use for these polymers has been as carriers for osteogenic agents.
Nelson et uI.*~ were first to assess the os-teogenic potential of PLA-PGA copolymer implants in the repair of bony wounds. The copolymer implants resulted in gradual healing of the bony wounds from the peripheries that progressed centrally. The implants were extremely tissue-tolerant with little inflammatory or foreign-body reaction. Olson et af.*' compared the tissue response of PLA with that of Gelfoam and Surgicel (Upjohn, Kalamazoo, Michigan) in healing tooth extraction sites. PLA was observed in the wounds after three months although its retention did not appear to interfere with new bone formation. PLA demonstrated less inflammatory reaction than either Gelfoam or Surgicel. Brekke et aL3 investigated the influence of PLA mesh on the incidence of localized alveolar osteitis. They concluded that the use of PLA mesh substantially reduced the incidence of mandibular third molar "wound failure" and that PLA demonstrated a hemostatic effect. Ho1linge1-l~ evaluated the osteogenic potential of PLA-PGA copolymer implants in osseous wounds. He showed that although the implant material was still present at 42 days, it displayed an accelerated rate of healing compared to control bony wounds. Hollinger13 was the first to use PLA-PGA as a carrier for a calcification initiator, diphosphoinositide-lysozyme (DPI-L). When DPI-L was combined with a PLA-PGA copolymer for the repair of endochondral wounds in rats and in the repair of mandibular discontinuity defects in dogs, the implants displayed an accelerated rate of repair compared to control w o~n d s . '~' '~ Higashi et al. l 2 used PLA-hydroxyapatite (PLA-HA) composites to repair endochondral wounds in rats. The PLA was rapidly resorbed in eight weeks and replaced by new bone that formed in direct contact with the HA.
BIOCOMPATIBILITY
There are no reports in the literature describing adverse systemic responses to polyester sutures or bone repair materials. Furthermore, the high degree of biocompatibility of PLA-PGA copolymers as bone implants has been d e~c r i b e d .~~'~.~~ This was further supported by the high degree of tissue tolerance seen with the demineralized bone/copolymer composite. A PLA-HA composite became drastically acidic in vitro, reaching a pH of 3.4 in one week and remaining at that level for five weeks.I2 This localized pH drop may account for the lack of a progressive and consistent healing pattern observed in many of the copolymer-DFDB composite implants. Additionally, the PLA-PGA composite appeared to possess a prolonged degradation time. Degradation commenced at the periphery and allowed exposure of the bone particles. This suggests that osseous repair proceeds from the margins. The TBA appeared to decrease over time, indicating that the optimum time for osteoinduction is between four and eight weeks. This is consistent with the sequence of osteoinductive events occurring heter~topically.~~
DEGRADATION
The process by which the alpha-hydroxy polyesters biodegrade is principally by nonspecific hydrolytic scission.22 Lactic acid, which is generated when PLA degrades, becomes incorporated into the tricarboxylic acid cycle and is excreted by the lungs as carbon dioxide and water.* PGA, in contrast, is broken down hydrolytically as well as by nonspecific esterases and carboxypeptida~es.~~ The resultant glycolic acid monomers are either excreted in the urine or enter the tricarboxylic acid cycle.
The rate at which the PLA-PGA implants degrade is dependent on five factors: (1) molar ratio of the constituents; (2) porosity of the implants; (3) vascularity of the recipient site;
(4) degree of crystallinity of the constituents; and (5) average molecular weight. In general, PLA-PGA copolymers with a greater molar ratio of PLA tend to degrade more slowly than those with a greater amount of PGA.' A 50:50 PLA:PGA molar ratio was chosen for this composite because its half-life appeared to be commensurate with normal fracture repair (four to six weeks).22
The total surface area of the polymer available for interface reactions with the host also appears to influence the rate of degradation. Porous implants will degrade more rapidly than dense glassy implants. During fabrication of the implants used in this study, the control of porosity was possible only to a limited extent. An ovemding concern was the fabrication of a rigid implant that could be carved and contoured at the time of surgery.
The degradation rate is also governed by the vascularity of the recipient site. Implants placed in the mandible appear to degrade more rapidly than implants placed in the calvaria.I6
The degree of polymer crystallinity significantly affects the rate of water sorption. Consequently, the L(-) form degrades more slowly than the D,L form.19320 Additionally, the alpha-hydroxy copolymers are less crystalline that their constituent homopolymers Schmitz and Hollinger and Related Research and will degrade more slowly.22 A 5050 poly(D,L-lactide-co-glycolide) implant was chosen because of its previous history of predictable degradation in endochondral wounds. l 4
An important factor governing degradation is the concept ofa polymer's average molecular weight, which is often described in terms of a polymer's inherent viscosity. Polymers that are highly viscous (high average molecular weight) will undergo slower biodegradation than those with a lower molecular weight and lower viscosity.15 The presence of residual polymer at 24 weeks may be attributed to its viscosity in a relatively avascular site (e.g., calvaria). Previous studies with this same copolymer in the repair of mandibular discontinuity defects showed complete biodegradation by eight to 12 weeks.15
MECHANISM OF ACTION
Allogeneic DFDB is postulated to provide a substratum for the differentiation of perivascular mesenchymal cells into chondrocytes and ultimately into osteoblasts. This process is known as osteoinduction. Urist et aL3' have proposed that the inductor was a protein, specifically, bone morphogenetic protein (BMP). In contrast, Reddi,29 Reddi and hug gin^,^^.^^ and Sampath and Reddi3' have proposed surface charge and geometry as well as inductor proteins as the putative factors in the osteoinduction process.
A sequential development of endochondral bone is initiated following the heterotopic implantation of decalcified bone mat r i~.~~ Initially, the implant forms a plaque consisting of a conglomerate of decalcified matrix, fibrin, and neutrophils. Limited proteolysis may cause the release of chemotactic factors and other matrix proteins into the surrounding milieu. The arrival of perivascular mesenchymal cells by chemotaxis is followed by their attachment to the bone matrix. The linear array of a random copolymer such as 5050 PLA:PGA, which remotely resembles the linear array of the collagen molecule, may play a crucial role in the anchorage dependency of cells.34 This anchorage dependency is essential in the early phase of the osteoinduction cascade. Cell attachment to bone matrix, thought to be promoted by fibronectin and related cell-adhesive proteins, helps to bring the putative inductor in contact with focal cell surface receptors. The subsequent release of mitogenic factors from the matrix (hSGF) helps to promote growth and proliferation of cells.36 These cells differentiate into chondrocytes and ultimately osteoblasts. Osteoblasts are subsequently anchored to the periphery of the decalcified bone particles and to elaborate osteoid in a vectorial fashion.
Particulate cancellous marrow bone grafts presently are considered the material of choice for maxillofacial bone grafts. These grafts are primarily used to stabilize mobile skeletal segments and to augment and construct new skeletal contour. However, the resorption ofthese grafts for certain utilities has been estimated to be in the range of 30%-70% of graft Demineralized bone powders, on the other hand, have not been reported to undergo resorption during bone induction and have complication rates no greater than those of conventional bone grafts. While one group has reported impressive clinical results,1°*ll-'8*24925 Mulliken et aLZ4 noted that bone powder failed to provide the immediate stability and structure needed in many types of skeletal reconstruction and construction. In this regard, PLA-PGA copolymers may be an acceptable carrier vehicle that also provides for immediate stability and structure conducive to repair of the craniofacial skeleton.
